Intravenous immunoglobulin therapy (IVIG) is a critical treatment modality in the management of a spectrum of immunodeficiencies, autoimmune disorders, and inflammatory conditions. Derived from pooled ...
Enjaymo is the first-and-only approved therapeutic option approved for hemolytic anemia in adult patients with cold agglutinin disease Paris, November 17, 2022. The European Commission (EC) has ...
The European medicines regulator said that a higher rate of death and disease complications in recent trials meant the ...
Zacks Investment Research on MSN
AGIO's Q3 Loss Narrower Than Expected, Pyrukynd Drives Y/Y Revenues
Agios Pharmaceuticals AGIO incurred a loss of $1.78 per share in the third quarter of 2025, narrower than the Zacks Consensus ...
EXTON, PA, July 29, 2025 (GLOBE NEWSWIRE) -- According to new findings from Spherix Global Insights’ syndicated Market Dynamix™ service, hematologists managing patients with warm autoimmune hemolytic ...
Detailed price information for 60 Degrees Pharmaceuticals Inc (SXTP-Q) from The Globe and Mail including charting and trades.
Her treatment plan, including transfusions and medication ... Doctors diagnosed Davis with warm autoimmune hemolytic anemia, ...
Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia. Recommendation based on LUNA 3 phase 3 study demonstrating rapid and durable platelet ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback